Your browser doesn't support javascript.
loading
Combined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis.
Vandewalle, Jolien; Timmermans, Steven; Paakinaho, Ville; Vancraeynest, Lies; Dewyse, Liza; Vanderhaeghen, Tineke; Wallaeys, Charlotte; Van Wyngene, Lise; Van Looveren, Kelly; Nuyttens, Louise; Eggermont, Melanie; Dewaele, Sylviane; Velho, Tiago R; Moita, Luis F; Weis, Sebastian; Sponholz, Christoph; van Grunsven, Leo A; Dewerchin, Mieke; Carmeliet, Peter; De Bosscher, Karolien; Van de Voorde, Johan; Palvimo, Jorma J; Libert, Claude.
Afiliación
  • Vandewalle J; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Timmermans S; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Paakinaho V; Institute of Biomedicine, University of Eastern Finland, Kuopio 70210, Finland.
  • Vancraeynest L; Department Basic and Applied Medical Sciences, Ghent University, Ghent 9000, Belgium.
  • Dewyse L; Liver Cell Biology research group, Vrije Universiteit Brussel (VUB), Brussels 1090, Belgium.
  • Vanderhaeghen T; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Wallaeys C; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Van Wyngene L; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Van Looveren K; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Nuyttens L; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Eggermont M; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Dewaele S; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium.
  • Velho TR; Instituto Gulbenkian de Ciência, Oeiras 2780-156, Portugal.
  • Moita LF; Instituto Gulbenkian de Ciência, Oeiras 2780-156, Portugal.
  • Weis S; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich-Schiller University, Jena 07743, Germany; Institute for Infectious Diseases and Infection Control, Jena University Hospital, Department of Anesthesiology and Intensive Care Medicine, Jena University Hospita
  • Sponholz C; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich-Schiller University, Jena 07743, Germany.
  • van Grunsven LA; Liver Cell Biology research group, Vrije Universiteit Brussel (VUB), Brussels 1090, Belgium.
  • Dewerchin M; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, Leuven 3000, Belgium.
  • Carmeliet P; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB, Leuven 3000, Belgium; Laboratory of Angiogenesis and Vascular Heterogeneity, Department of Biomedicine, Aarhus University, Aarhus 8000, Denmark
  • De Bosscher K; Translational Nuclear Receptor Research lab, VIB Center for Medical Biotechnology, VIB, Ghent 9052, Belgium; Department of Biomolecular Medicine, Ghent University, Ghent 9052, Belgium.
  • Van de Voorde J; Department Basic and Applied Medical Sciences, Ghent University, Ghent 9000, Belgium.
  • Palvimo JJ; Institute of Biomedicine, University of Eastern Finland, Kuopio 70210, Finland.
  • Libert C; VIB Center for Inflammation Research, VIB, Ghent 9052, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent 9052, Belgium. Electronic address: claude.libert@irc.vib-ugent.be.
Cell Metab ; 33(9): 1763-1776.e5, 2021 09 07.
Article en En | MEDLINE | ID: mdl-34302744
Sepsis is a potentially lethal syndrome resulting from a maladaptive response to infection. Upon infection, glucocorticoids are produced as a part of the compensatory response to tolerate sepsis. This tolerance is, however, mitigated in sepsis due to a quickly induced glucocorticoid resistance at the level of the glucocorticoid receptor. Here, we show that defects in the glucocorticoid receptor signaling pathway aggravate sepsis pathophysiology by lowering lactate clearance and sensitizing mice to lactate-induced toxicity. The latter is exerted via an uncontrolled production of vascular endothelial growth factor, resulting in vascular leakage and collapse with severe hypotension, organ damage, and death, all being typical features of a lethal form of sepsis. In conclusion, sepsis leads to glucocorticoid receptor failure and hyperlactatemia, which collectively leads to a lethal vascular collapse.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sepsis / Hiperlactatemia Límite: Animals Idioma: En Revista: Cell Metab Asunto de la revista: METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sepsis / Hiperlactatemia Límite: Animals Idioma: En Revista: Cell Metab Asunto de la revista: METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Bélgica Pais de publicación: Estados Unidos